The Healthcare System Futures 2016 scenarios are taking shape (and will form the basis of one set of stimulus materials for my session at next week’s eyeforpharma Engage with the new NHS conference on 27th / 28th September in London).
Here is the scenario grid that I have developed, and below the emerging stories:
The rise of the health consumer
Patients are able to exercise choice and readily do so, supported by their healthcare professionals. The health care system – including the NHS – increasingly recognises their pre-eminence as consumers.
The QIPP agenda to promote quality, innovation, productivity and prevention has been very successful, so the pace and scale of innovation in the healthcare sector has been rapid and significant.
The rate at which provider organisations are able to effectively respond to the evolving commissioning landscape has been positive leading to more choice of better services against increasing patient / consumer demand.
Where personal wealth allows, patients are willing to pay directly for / "top up" their healthcare.
New and existing players are actively seeking to expand their influence and the services they provide to meet growing demand driven by innovative commissioning and greater evidence of patients exercising choice.
Any takers?
Patients are generally unable or unwilling to exercise choice despite effective implementation of new commissioning arrangements. Even with the’ development of consumer capacity within the healthcare system, there is little confidence that the ability to exercise genuine choice is a reality.
The QIPP agenda to promote quality, innovation, productivity and prevention has been very successful, so the pace and scale of innovation in the healthcare sector has been rapid and significant.
The rate at which provider organisations are able to effectively respond to the evolving commissioning landscape has been positive leading to more choice of better services, but patient driven demand has been limited.
Patients remain reluctant to pay directly for / "top up" their healthcare, feeling that the original principles of public healthcare provision in the UK should remain in force.
New players are reluctant to enter the market due to evidence of limited choice being made by patients.
It’s all too much
Patients are generally unable or unwilling to exercise choice, a situation exacerbated by poor and ineffective implementation of new commissioning arrangements. There is no confidence that genuine choice will become a reality.
The QIPP agenda to promote quality, innovation, productivity and prevention has largely failed so the pace and scale of innovation in the healthcare sector has been very limited.
The rate at which provider organisations are able to effectively respond to the evolving commissioning landscape has been very limited as commissioners struggle to adopt to the new commissioning arrangements. However, patient driven demand has been limited so there has been limited patient backlash.
Patients remain reluctant to pay directly for / "top up" their healthcare, feeling that the original principles of public healthcare provision in the UK should remain in force.
Given this backdrop, new players have not entered the market.
Broken promises
Patients are aware of their ability to make choices in the treatment they receive in theory, but find the reality very different. Poor and ineffective implementation of new commissioning arrangements has been identified as a major hurdle in promoting choice which is giving rise to an increasingly frustrated patient population.
The QIPP agenda to promote quality, innovation, productivity and prevention has largely failed so the pace and scale of innovation in the healthcare sector has been very limited.
The rate at which provider organisations are able to effectively respond to the evolving commissioning landscape has been very limited as commissioners struggle to adopt to the new commissioning arrangements. However, patient driven demand has been high and tensions are rising amongst the public as the health service is roundly criticised for not meeting demand.
Where personal wealth allows, patients are willing to pay directly for / "top up" their healthcare to ensure they get the care they think they deserve.
Given this commissioning backdrop, new players have not entered the market.
If you want to get involed in this work or want to know more, contact me via the informing choices website.
